The largest database of trusted experimental protocols

17 protocols using antisedan

1

Medetomidine-Atipamezole Reversal Dosing

Check if the same lab product or an alternative is used in the 5 most similar protocols
medetomidine (1000 µg/mL, Domitor; Nippon Zenyaku Kogyo Co., Ltd., Fukushima, Japan) at a dose of 200 µg/kg was administered intramuscularly to rats in all groups. Fifteen minutes after medetomidine administration, atipamezole (5000 µg/mL, Antisedan; Nippon Zenyaku Kogyo Co., Ltd., Fukushima, Japan) at doses of 400, 800, or 1600 µg/kg or 0.32 mL/kg saline solution (equal volume to 1600 µg/kg atipamezole) was administered. According to the treatment received, groups were named MA400, MA800, MA1600, and control groups, respectively. The drug solution was injected into the caudal part of the left thigh using a microsyringe (1/2 mL BD Lo-Dose Insulin Syringe 29 G × 1/2 inch; BD, Franklin Lakes, NJ, USA) at 10:00 a.m.
+ Open protocol
+ Expand
2

Embryo Transfer in Rat Pseudopregnancy

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fertilized oocytes obtained by IVF (pronuclear fertilized oocytes and two-cell embryos in monospermic fertilization) were transferred into the oviducts of pseudo-pregnant Crl:CD(SD) female
rats produced by mating female rats at proestrus, as observed by vaginal smears with vasectomized Crlj:CD(SD) male rats before embryo transfer. Anesthesia was performed using a mix of three
anesthetic agents intraperitoneally administered at a dose of 0.5 ml per 100 g of body weight. We transferred 6–12 fertilized oocytes to both sides of the oviduct. After embryo transfer, an
antagonist (Antisedan, 150 µg/ml, NIPPON ZENYAKU KOGYO Co., Ltd., Fukushima, Japan) was intraperitoneally administered at a dose of 0.5 ml per 100 g of body weight. The number of pups was
counted 22–23 days after the embryo transfer. The birth rate was calculated as the number of live pups divided by the number of transferred embryos, multiplied by 100.
+ Open protocol
+ Expand
3

Multimodal Anesthesia Protocol for Small Animals

Check if the same lab product or an alternative is used in the 5 most similar protocols
MMB consisted of a combination of medetomidine (Domitol, Nippon Zenyaku Kogyo Co., Ltd.,
Fukushima, Japan), midazolam (Dormicum, Astellas Pharma, Inc., Tokyo, Japan) and
butorphanol (Vetorphale, Meiji Seika Pharma Co., Ltd., Tokyo, Japan). Atipamezole
(Antisedan, Nippon Zenyaku Kogyo Co., Ltd.) was used as a medetomidine antagonist. All
drugs were stored at ordinary temperature (15 to 25°C) until use.
+ Open protocol
+ Expand
4

Uterine Tissue Transfer for Estrogen Priming

Check if the same lab product or an alternative is used in the 5 most similar protocols
The CAG-ELuc female mice as donors and C57BL/6 female mice (wild type) as recipient were anesthetized with M/M/B anesthesia as described above. They were ovariectomized and injected with E2
(Estradiol valerate, Progynon®-Depot, Fuji Pharma Co., Ltd., Toyama, Japan, 0.5 or 0.2 µg/mouse, according to each experimental condition) subcutaneously. After
surgery, they were awoken by administration of atipamezole (ANTISEDAN®, Nippon Zenyaku Kogyo Co., Ltd., 0.3 mg/kg body weight) that is antagonistic to medetomidine. One week
later, the donor mice were sacrificed by cervical dislocation, and their uteri were removed. Half of the uterus was minced in 300 µl of saline. The minced uterine tissues
were transferred into the peritoneal cavity of the recipient mice under anesthesia (i.e., 1:2 donor uterus to recipient ratio), and the surgery hole was sutured. Subsequently, the recipient
mice were administered E2 (0.5 or 0.2 µg/mouse). After uterus transfer, E2 was injected into the recipient mice once a week.
+ Open protocol
+ Expand
5

Murine Myocardial Infarction Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
MI was induced as previously described.51 (link) Mice were deeply anesthetized with an intraperitoneal injection of MMB (0.1 mL per 10 g). Overall, the mice were intubated using a small rodent ventilator (MiniVent 845, Harvard Apparatus, Holliston, MA). Left lateral thoracotomy was performed, and the LAD coronary artery was ligated using an 8/0 nylon suture after removing the pericardium. The chest was closed, antipamezole (0.75 mg·kg−1; Antisedan; Nippon Zenyaku Kogyo Co., Ltd.) was administered for reversal, and then the mice were removed from the respirator. The mice were allowed to recover on a warm surface. Sham mice underwent all procedures except for actual LAD occlusion. Some mice were examined until 28 days after MI to analyze survival. The other mice were examined until 7 days after MI and then sacrificed to obtain samples. All mice were necropsied to obtain evidence regarding post-MI cardiac rupture or heart failure as described previously.52 (link)
+ Open protocol
+ Expand
6

Anesthetic Agents and Antagonist Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Medetomidine hydrochloride (Dorbene®, Kyoritsuseiyaku Corp., Tokyo, Japan), midazolam (Dormicum®, Astellas Pharma Inc., Tokyo, Japan), butorphanol
(Vetorphale®, Meiji Seika Pharma Co., Ltd., Tokyo, Japan) and sodium pentobarbital (Somnopentyl®, Kyoritsuseiyaku Corp.) were used as the anesthetic agents.
Atipamezole (Antisedan®, Nippon Zenyaku Kogyo Co., Ltd., Fukushima, Japan) was used as an antagonist of medetomidine.
Medetomidine, midazolam and butorphanol were mixed and diluted with saline (Otsuka Normal Saline®, Otsuka Pharmaceutical Factory, Inc., Tokushima, Japan) to concentrations of
0.03, 0.4 and 0.5 mg/ml, respectively [11 (link)]. Pentobarbital was diluted with saline to a concentration of 10 mg/ml.
Atipamezole was diluted with saline to concentrations of 0.03 and 0.15 mg/ml. The anesthetics and atipamezole were administered at the dosing volume of 5
ml/kg. In the case of need for additional anesthesia, the respective anesthetic agents were administered at the dose volume of 1 ml/kg until complete
anesthesia was induced (up to an anesthesia score of 5, as described below).
+ Open protocol
+ Expand
7

Maxillary Molar Extraction and Tissue Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The maxillary molars were extracted under anesthesia with triple anesthesia (medetomidine hydrochloride 0.75 mg/kg (Domitol, Nippon Zenyaku Kogyo Co.,Ltd. Fukushima, Japan), midazolam 4.0 mg/kg (Dormicum, Sandoz K. K., Tokyo, Japan), butorphanol 5.0 mg/kg (Vetorphale, Meiji Seika Pharma Co., Ltd. Tokyo, Japan)) using hooked-end forceps. After surgery, mice were injected with Atipamezole 0.75 mg/kg (antisedan, Nippon Zenyaku Kogyo Co.,Ltd.) to antagonize the anesthesia effect. Two weeks later, the tissue from the extraction socket was collected and used for analysis.
+ Open protocol
+ Expand
8

Anesthetic Dosing for Rodent Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
In the present study, we used pharmaceutical-grade products as follows: medetomidine hydrochloride (Domitor®; Nippon Zenyaku Kogyo Co., Ltd., Fukushima, Japan), midazolam hydrochloride (Dormicum®; Astellas Pharma Inc., Tokyo, Japan), butorphanol tartrate (Vetorphale®; Meiji Seika Pharma Co., Ltd., Tokyo, Japan) and atipamezole hydrochloride (Antisedan®; Nippon Zenyaku Kogyo Co., Ltd.). In addition, the doses of these agents used in this study were described as follows: medetomidine (0.1, 0.2 and 0.3 mg/kg), midazolam (4.0 mg/kg), butorphanol (5.0 mg/kg), the midazolam-butorphanol mixture (4.0/5.0 mg/kg), the three-anesthetic mixture (Me/Mi/Bu: 0.3/4.0/5.0, 0.3/6.0/7.5, 0.15/6.0/7.5, 0.15/6.0/10.0, 0.2/6.0/7.5 and 0.2/6.0/10.0 mg/kg) and atipamezole (Ati: 0.3, 0.6, 1.2, and 2.4 mg/kg). These drugs were diluted in sterile saline to 0.1 ml/10 g bodyweight of the animal and were administered by intraperitoneal injection (IP) in this study.
+ Open protocol
+ Expand
9

Stab Wound Surgery in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Stab wound surgery was performed using a modified version of the procedure previously described by Hashimoto et al.18 (link). Mice (6 weeks old) were anaesthetised by a mixture of 0.75 mg/kg Domitor (Nippon Zenyaku Kogyo, Fukushima, Japan), 4 mg/kg midazolam (Sandoz, Holzkirchen, Germany), and 5 mg/kg Vetorphale (Meiji Seika Pharma, Tokyo, Japan). A 19-gauge needle was then used to penetrate the skull in the occipital region of the right hemisphere, and a 27-gauge needle was inserted through this hole along the rostrocaudal axis, and the needle was pulled out gently to induce just one stab wound to the right cerebral cortex. After the operation, the Domitor antagonist Antisedan (0.75 mg/kg; Nippon Zenyaku Kogyo) was injected intraperitoneally to facilitate recovery from anaesthesia. A sample size calculation was based on our previous study18 (link).
+ Open protocol
+ Expand
10

Anesthesia and Postoperative Care Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Animals were pre-anesthetized with an intramuscular injection of 0.04 mg/kg of medetomidine (Domitor; Nippon Zenyaku Kogyo, Koriyama, Japan), 0.40 mg/kg of midazolam (Dormicam 10 mg; Astellas Pharma, Tokyo, Japan), and 0.40 mg/kg of butorphanol (Vetorphale; Meiji Seika Pharma, Tokyo, Japan). They were also administered 15 mg/kg ampicillin (Viccillin; Meiji Seika Pharma, Co., Ltd.) and hydrated subcutaneously with 2 mL/head of fluid (KN No.1 injection; Otsuka Pharmaceutical, Tokyo, Japan). Thereafter, animals were anesthetized by inhalation with 1.0–3.0% isoflurane (Forane; Abbott Japan, Tokyo, Japan) via a ventilation mask. Anesthetization management was performed by spontaneous respiration during the operation, monitoring the heart rate and the arterial oxygen saturation. After oocyte collection or embryo transfer, 0.20 mg/kg atipamezole (Antisedan; Nippon Zenyaku Kogyo) was administered intramuscularly into the animals. For postoperative analgesia and infection control, 1.2 mg/kg ketprofen and 15 mg/kg ampicillin were administered once daily for 3 consecutive days following the operations.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!